Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-19

Clinical Trial Update: Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vagus nerve stimulation for moderate to severe rheumatoid arthritis has posted results. The study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vagus nerve stimulation (vagus nerve stimulation)

Snippet

Sponsor: SetPoint Medical Corporation | Conditions: Rheumatoid Arthritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-12-19